AIM ImmunoTech Inc. — Director's Dealing 2015

Apr 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2015-04-17

Reporting Person: CARTER WILLIAM A (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-17	Common Stock	P	73681	$0.23	Acquired	950585	Direct